BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.93% | -291.41% | 89.56% | 9.04% | -318.93% |
| Total Depreciation and Amortization | -2.85% | -1.68% | 76.73% | -6.48% | -0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.33% | 162.04% | -118.35% | 22.50% | 2,039.01% |
| Change in Net Operating Assets | -1,479.17% | -106.98% | 169.35% | -65.89% | -140.51% |
| Cash from Operations | -35.82% | -83.61% | 39.29% | 47.29% | -200.90% |
| Capital Expenditure | 23.24% | 70.02% | -669.37% | 23.71% | 33.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -117.50% | 117.78% | -- | -- | -- |
| Cash from Investing | 15.25% | 75.58% | -770.72% | 23.71% | 33.86% |
| Total Debt Issued | -- | -- | -- | -- | 455.48% |
| Total Debt Repaid | -424.39% | -37.82% | 7.75% | -43.33% | 5.26% |
| Issuance of Common Stock | -- | -100.00% | 36,246.15% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,596.34% | -103.56% | 4,070.69% | -101.66% | 492.48% |
| Foreign Exchange rate Adjustments | -760.00% | -129.41% | 666.67% | -104.17% | 7,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.25% | -238.57% | 190.26% | -150.55% | 1,600.40% |